Stockreport

IN8bio Announces Clinical Pipeline Prioritization to Focus on INB-100 for Acute Myeloid Leukemia [Yahoo! Finance]

IN8bio, Inc.  (INAB) 
PDF patients into the expansion cohort to further support the observed 100% progression-free survival in AML patients as of August 30, 2024. Suspending enrollment of Phase [Read more]